Published 3 days ago • loading... • Updated 3 days ago

Should drug companies be advertising to consumers?

This month the U.S. Food and Drug Administration notified Novo Nordisk that it found a TV spot false and misleading, while senators proposed a ban on prescription drug ads.
The debate dates to 1997 when the FDA loosened rules to allow prescription drug TV ads, which expanded after Medicare Part D ; only the U.S. and New Zealand permit direct-to-consumer advertising.
The U.S. Food and Drug Administration issued 100 cease-and-desist orders and sent 'thousands' of warnings about deceptive drug ads, while MediaRadar data show Novo Nordisk spent $180 million in 2022 and $189 million in 2023.
Research shows direct-to-consumer ads influence prescription rates, prompting more patient requests, and public health advocates warn ads encourage use of costly new drugs over generic and older drugs.
Last February, efforts to restrict advertising faced legal hurdles due to the Supreme Court's Citizens United ruling, which protects corporate speech, despite proposed bills to ban direct-to-consumer ads for three years after FDA approval.

Insights by Ground AI

42 Articles

Broomfield Enterprise

+41 Reposted by 41 other sources

Center

Should drug companies be advertising to consumers?

By Paula Span, KFF Health News Tamar Abrams had a lousy couple of years in 2022 and ’23. Both her parents died; a relationship ended; she retired from communications consulting. She moved from Arlington, Virginia, to Warren, Rhode Island, where she knew all of two people. Related Articles 80 students, adults excluded from Broomfield schools during measles outbreak How springing forward to daylight saving time could…

3 days ago·Denver, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year